Adalimumab treatment of life-threatening tuberculosis
RS Wallis, C van Vuuren… - Clinical infectious …, 2009 - academic.oup.com
RS Wallis, C van Vuuren, S Potgieter
Clinical infectious diseases, 2009•academic.oup.comMost guidelines call for the discontinuation of treatment with tumor necrosis factor blockers
in patients who develop tuberculosis. We report a case of life-threatening tuberculosis
paradoxical reaction involving the lungs caused by withdrawal of the anti–tumor necrosis
factor antibody adalimumab. Clinical improvement occurred only after resumption of
adalimumab treatment.
in patients who develop tuberculosis. We report a case of life-threatening tuberculosis
paradoxical reaction involving the lungs caused by withdrawal of the anti–tumor necrosis
factor antibody adalimumab. Clinical improvement occurred only after resumption of
adalimumab treatment.
Abstract
Most guidelines call for the discontinuation of treatment with tumor necrosis factor blockers in patients who develop tuberculosis. We report a case of life-threatening tuberculosis paradoxical reaction involving the lungs caused by withdrawal of the anti–tumor necrosis factor antibody adalimumab. Clinical improvement occurred only after resumption of adalimumab treatment.
Oxford University Press